AP2001002312A0 - New aromatic amides sustituted by a ribose, their preparation process and their use as medicaments. - Google Patents

New aromatic amides sustituted by a ribose, their preparation process and their use as medicaments.

Info

Publication number
AP2001002312A0
AP2001002312A0 APAP/P/2001/002312A AP2001002312A AP2001002312A0 AP 2001002312 A0 AP2001002312 A0 AP 2001002312A0 AP 2001002312 A AP2001002312 A AP 2001002312A AP 2001002312 A0 AP2001002312 A0 AP 2001002312A0
Authority
AP
ARIPO
Prior art keywords
alkyl
hydrogen
sustituted
ribose
medicaments
Prior art date
Application number
APAP/P/2001/002312A
Other languages
English (en)
Inventor
Jacques Demassey
Michel Klich
Branislav Musicki
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AP2001002312A0 publication Critical patent/AP2001002312A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06Benzopyran radicals
    • C07H17/065Benzo[b]pyrans
    • C07H17/075Benzo[b]pyran-2-ones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
APAP/P/2001/002312A 1999-04-19 2000-04-18 New aromatic amides sustituted by a ribose, their preparation process and their use as medicaments. AP2001002312A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904866A FR2792320B1 (fr) 1999-04-19 1999-04-19 Nouveaux amides aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
PCT/FR2000/000999 WO2000063222A2 (fr) 1999-04-19 2000-04-18 Nouveaux amides aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
AP2001002312A0 true AP2001002312A0 (en) 2001-12-31

Family

ID=9544554

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2001/002312A AP2001002312A0 (en) 1999-04-19 2000-04-18 New aromatic amides sustituted by a ribose, their preparation process and their use as medicaments.

Country Status (24)

Country Link
US (1) US6579902B1 (enExample)
EP (1) EP1173455A2 (enExample)
JP (1) JP2002542253A (enExample)
KR (1) KR100693258B1 (enExample)
CN (1) CN1213055C (enExample)
AP (1) AP2001002312A0 (enExample)
AU (1) AU769514B2 (enExample)
CA (1) CA2363945A1 (enExample)
CZ (1) CZ20013708A3 (enExample)
EA (1) EA004304B1 (enExample)
FR (1) FR2792320B1 (enExample)
HK (1) HK1046690B (enExample)
HU (1) HUP0200778A3 (enExample)
ID (1) ID30562A (enExample)
IL (1) IL146018A0 (enExample)
NO (1) NO320703B1 (enExample)
NZ (1) NZ515108A (enExample)
PL (1) PL354192A1 (enExample)
SK (1) SK14842001A3 (enExample)
TR (1) TR200103009T2 (enExample)
UA (1) UA72919C2 (enExample)
WO (1) WO2000063222A2 (enExample)
YU (1) YU80301A (enExample)
ZA (1) ZA200108627B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2844273B1 (fr) * 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
US7439253B2 (en) * 2002-12-06 2008-10-21 Novexel Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors
KR100649357B1 (ko) * 2004-05-04 2006-11-24 제일약품주식회사 항염증 활성을 갖는 크로멘-2-온 모핵 히드록사민 산유도체, 이의 제조방법 및 이를 포함하는 염증 질환의치료를 위한 조성물
US8212011B2 (en) * 2004-11-03 2012-07-03 University Of Kansas Novobiocin analogues
US9120774B2 (en) 2004-11-03 2015-09-01 University Of Kansas Novobiocin analogues having modified sugar moieties
US7608594B2 (en) * 2004-11-03 2009-10-27 University Of Kansas Novobiocin analogues as anticancer agents
US7622451B2 (en) * 2004-11-03 2009-11-24 University Of Kansas Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
US8212012B2 (en) * 2004-11-03 2012-07-03 University Of Kansas Novobiocin analogues having modified sugar moieties
US7960353B2 (en) * 2007-05-10 2011-06-14 University Of Kansas Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
WO2010014617A1 (en) * 2008-07-28 2010-02-04 University Of Kansas Heat shock protein 90 inhibitor dosing methods
US20110082098A1 (en) * 2009-09-30 2011-04-07 University Of Kansas Novobiocin analogues and treatment of polycystic kidney disease
US11827664B2 (en) 2018-05-14 2023-11-28 Reata Pharmaceuticals, Inc Biaryl amides with modified sugar groups for treatment of diseases associated with heat shock protein pathway

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652536A (en) * 1969-06-02 1972-03-28 Upjohn Co Novenamine compounds and derivatives
US3890297A (en) * 1973-03-29 1975-06-17 Upjohn Co Process for n-acylating novenamine

Also Published As

Publication number Publication date
EA004304B1 (ru) 2004-02-26
EA200101100A1 (ru) 2002-04-25
FR2792320B1 (fr) 2003-05-09
WO2000063222A3 (fr) 2001-05-31
NO20015058L (no) 2001-12-17
YU80301A (sh) 2005-07-19
FR2792320A1 (fr) 2000-10-20
HUP0200778A3 (en) 2003-03-28
IL146018A0 (en) 2002-07-25
AU769514B2 (en) 2004-01-29
PL354192A1 (en) 2003-12-29
ZA200108627B (en) 2002-10-21
KR20020008155A (ko) 2002-01-29
CA2363945A1 (fr) 2000-10-26
TR200103009T2 (tr) 2002-05-21
HK1046690A1 (en) 2003-01-24
UA72919C2 (uk) 2005-05-16
NZ515108A (en) 2004-01-30
ID30562A (id) 2001-12-20
WO2000063222A2 (fr) 2000-10-26
EP1173455A2 (fr) 2002-01-23
CZ20013708A3 (cs) 2002-04-17
CN1357001A (zh) 2002-07-03
KR100693258B1 (ko) 2007-03-13
US6579902B1 (en) 2003-06-17
JP2002542253A (ja) 2002-12-10
HUP0200778A2 (hu) 2002-07-29
SK14842001A3 (sk) 2003-05-02
NO320703B1 (no) 2006-01-16
AU4125600A (en) 2000-11-02
CN1213055C (zh) 2005-08-03
HK1046690B (zh) 2006-03-10
NO20015058D0 (no) 2001-10-18

Similar Documents

Publication Publication Date Title
AP2001002312A0 (en) New aromatic amides sustituted by a ribose, their preparation process and their use as medicaments.
MY126951A (en) Beta2-adrenoceptor agonists
MY127144A (en) New anticholinergics which may be used as medicaments as well as processes for preparing them
HUP9903766A2 (en) Pyridyl alkene- and pyridyl alkine- acid amides, use of them as cytostatics and immunosuppressives, process for their preparation and pharmaceuticals containing the same
MX9800867A (es) Halogenobencimidazoles y su empleo como microbicidas.
TW349941B (en) Substituted N-heteroaroylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them
YU68792A (sh) Postupak za dobivanje derivata bakatina iii i 10-dezacetil-bakatina iii
GB0018272D0 (en) Chemical compounds IV
IL158343A (en) Dopamine glycoconjugate compounds, pharmaceutical compositions comprising them, processes for their preparation and use thereof in the manufacture of medicaments and as medicaments for treating parkinson's disease
HU9403802D0 (en) Process for alkoxymethylation of pyrroles
MXPA05010651A (es) Compuestos de pirazol.
IE790592L (en) Heterocyclyl carbonyl ureas
MY132057A (en) Quinoxalinones, a process for their preparation and their use
MXPA06002919A (es) Sustancias colorantes azoicas dispersas.
NZ332597A (en) Alkyloxyamino substituted fluoren-9-ones and their use as protein kinase c inhibitors
TW353660B (en) Novel diarylmethylidenefuran derivatives, process for their preparation and their uses in therapeutics
MXPA01013148A (es) Nuevos derivados de amonio cuaternario, metodo para la preparacion de los mismos y uso farmaceutico.
DE69029781D1 (de) Anthracyclinglycosid-Derivate und Verfahren zu ihrer Herstellung
TW259785B (en) Chemical compounds
GB2334032A (en) Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents
NZ510116A (en) Tricyclic delta-3-piperidines as pharmaceuticals
EP0339834A3 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
TWI263639B (en) Novel tetrazole derivative
UA41348C2 (uk) Проліки 3-ацил-2-оксіндол-1-карбоксамідів та фармацевтична композиція
TW330147B (en) Halogenobenzimidazoles, their preparation processes and their use